An international team of researchers has, for the first time, created a detailed map of the location and identity of individual cells in the adult lung, both from healthy lungs and in lungs from ...
Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibrosis (IPF) drug with a second phase 3 win in ...
In what one analyst called a “unique situation,” the company stopped dosing patients on the recommendation of trial monitors, ...
Pliant Therapeutics has pumped the breaks on a mid-stage trial of its lead liver disease drug on the advice of its safety ...
A charity, Action for Pulmonary Fibrosis (APF) say that "rounded and swollen fingertips (clubbed fingers)" could be a sign of a fatal disease. Idiopathic pulmonary fibrosis (IPF) is a condition in ...
With Trevi poised to soon announce data from a trial of its Haduvio drug as a treatment for refractory chronic cough (RCC), ...
The experts will assess unblinded data from BEACON-IPF to figure out why a data safety monitoring board recommended ...
It is unclear why an independent data safety monitoring board recommended the suspension of Pliant’s Phase IIb/III BEACON-IPF ...
Researchers from the European Molecular Biology Laboratory have found that dextromethorphan, a common cough syrup ingredient, ...
Qureight Ltd, a Core Imaging Laboratory developing deep-learning image analytics, and Vicore Pharma, a clinical-stage biopharmaceutical company unlocking the potential of angiotensin II type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback